Linked Life Data

8874347

Source:http://linkedlifedata.com/resource/pubmed/id/8874347

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1996-11-12
pubmed:abstractText
The primary objective was to determine clinical practice guidelines for the use of tumor marker tests in the prevention, screening, treatment, and surveillance of breast and colorectal cancers. These guidelines are intended for use in the care of patients outside of clinical trials.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/CA-19-9 Antigen, http://linkedlifedata.com/resource/pubmed/chemical/Carcinoembryonic Antigen, http://linkedlifedata.com/resource/pubmed/chemical/Cathepsin D, http://linkedlifedata.com/resource/pubmed/chemical/Genetic Markers, http://linkedlifedata.com/resource/pubmed/chemical/Lipids, http://linkedlifedata.com/resource/pubmed/chemical/Mucin-1, http://linkedlifedata.com/resource/pubmed/chemical/N-Acetylneuraminic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53, http://linkedlifedata.com/resource/pubmed/chemical/lipid-associated sialic acid
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0732-183X
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:pagination
2843-77
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:8874347-Breast Neoplasms, pubmed-meshheading:8874347-CA-19-9 Antigen, pubmed-meshheading:8874347-Carcinoembryonic Antigen, pubmed-meshheading:8874347-Cathepsin D, pubmed-meshheading:8874347-Colorectal Neoplasms, pubmed-meshheading:8874347-Flow Cytometry, pubmed-meshheading:8874347-Genes, p53, pubmed-meshheading:8874347-Genes, ras, pubmed-meshheading:8874347-Genetic Markers, pubmed-meshheading:8874347-Humans, pubmed-meshheading:8874347-Lipids, pubmed-meshheading:8874347-Mucin-1, pubmed-meshheading:8874347-N-Acetylneuraminic Acid, pubmed-meshheading:8874347-Ploidies, pubmed-meshheading:8874347-Receptor, erbB-2, pubmed-meshheading:8874347-Receptors, Estrogen, pubmed-meshheading:8874347-Receptors, Progesterone, pubmed-meshheading:8874347-Tumor Markers, Biological, pubmed-meshheading:8874347-Tumor Suppressor Protein p53
pubmed:year
1996
pubmed:articleTitle
Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology.
pubmed:publicationType
Journal Article, Guideline, Practice Guideline